Anika Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
14.58 M |
Public Float |
10.11 M |
Anika Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.06 |
Market Cap |
$584.76 M |
Shares Outstanding |
14.21 M |
Public Float |
13.63 M |
Address |
32 Wiggins Avenue Bedford Massachusetts 01730 United States |
Employees | - |
Website | http://www.anikatherapeutics.com |
Updated | 07/08/2019 |
Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary. |